Status:
WITHDRAWN
Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?
Lead Sponsor:
Norwegian School of Sport Sciences
Conditions:
Sports Drug Abuse
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The prevalence of asthma among athletes is higher than in the normal population and endurance athletes are especially at increased risk. The gold standard for asthma treatment is inhaled glucocorticoi...
Detailed Description
Theoretical background: The use of beta2-agonists in sports is restricted due to possible performance enhancing effects. The World Anti-Doping Agency's (WADA) prohibited list from January the 1st 202...
Eligibility Criteria
Inclusion
- well trained cyclists and triathletes (VO2max in mLˑkg-1ˑmin-1 ≥ 65 male/55 female) who are actively engaged in endurance cycling training at least 4 times per week.
Exclusion
- a doctor diagnosed asthma and/or the use of anti-asthmatic medications the last 12 months prior to participation.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04402658
Start Date
August 1 2022
End Date
December 20 2023
Last Update
March 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.